Century Therapeutics Inc. Watch

from SC 13G/A ~1 page Joint Filing Agreement Pursuant to Rule 13d-1

from 8-K 107 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Agreement and Plan of Merger Among: Century Therapeutics, Inc., a Delaware Corporation; Clarent Intermediate Sub, Inc., a Delaware Corporation; Clarent Merger Sub, Inc., a Delaware Corporation; Clade Therapeutics, Inc., a Delaware Corporation; and Fortis Advisors LLC, as the Securityholders’ Agent Dated as of April 11, 2024